Viva Biotech Holdings (01873) Announces Monthly Return on Movements in Securities for February 2026

Bulletin Express03-03

Viva Biotech Holdings (01873) released its monthly return for February 2026, indicating that the authorized share capital remained at 4.00 billion ordinary shares with a par value of USD 0.000025 each, translating into total authorized share capital of USD 100,000. The number of issued shares stayed at 2.13 billion, with no changes during the month. The public float requirement remains at 25%, and there were no new share issuances, cancellations, or treasury share movements.

Pre-IPO share incentives stood at 2.22 million outstanding options, while post-IPO share options were 18.02 million. No additional shares were issued or canceled under these plans. The post-IPO plan allows for a maximum of 120.03 million shares to be issued or transferred. No funds were raised from share-option exercises in the reporting period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1120684455?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 15:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120684455","market":"hk","top_or_hot":-1,"title":"Viva Biotech Holdings (01873) Announces Monthly Return on Movements in Securities for February 2026","media":"Bulletin Express","content":"<p>Viva Biotech Holdings (01873) released its monthly return for February 2026, indicating that the authorized share capital remained at 4.00 billion ordinary shares with a par value of USD 0.000025 each, translating into total authorized share capital of USD 100,000. The number of issued shares stayed at 2.13 billion, with no changes during the month. The public float requirement remains at 25%, and there were no new share issuances, cancellations, or treasury share movements.</p>\n<p>Pre-IPO share incentives stood at 2.22 million outstanding options, while post-IPO share options were 18.02 million. No additional shares were issued or canceled under these plans. The post-IPO plan allows for a maximum of 120.03 million shares to be issued or transferred. No funds were raised from share-option exercises in the reporting period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Viva Biotech Holdings (01873) Announces Monthly Return on Movements in Securities for February 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nViva Biotech Holdings (01873) Announces Monthly Return on Movements in Securities for February 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-03 15:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Viva Biotech Holdings (01873) released its monthly return for February 2026, indicating that the authorized share capital remained at 4.00 billion ordinary shares with a par value of USD 0.000025 each, translating into total authorized share capital of USD 100,000. The number of issued shares stayed at 2.13 billion, with no changes during the month. The public float requirement remains at 25%, and there were no new share issuances, cancellations, or treasury share movements.</p>\n<p>Pre-IPO share incentives stood at 2.22 million outstanding options, while post-IPO share options were 18.02 million. No additional shares were issued or canceled under these plans. The post-IPO plan allows for a maximum of 120.03 million shares to be issued or transferred. No funds were raised from share-option exercises in the reporting period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01873","symbol_name":"维亚生物","start_time":0,"source_url":"","article_id":"1120684455","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120684455","pubTimestamp":1772521454,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Viva Biotech Holdings (01873) released its monthly return for February 2026, indicating that the authorized share capital remained at 4.00 billion ordinary shares with a par value of USD 0.000025...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01873":"维亚生物"},"translate_title":"维亚生物控股(01873)公布2026年2月证券变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01873":1},"content_text":"Viva Biotech Holdings (01873) released its monthly return for February 2026, indicating that the authorized share capital remained at 4.00 billion ordinary shares with a par value of USD 0.000025 each, translating into total authorized share capital of USD 100,000. The number of issued shares stayed at 2.13 billion, with no changes during the month. The public float requirement remains at 25%, and there were no new share issuances, cancellations, or treasury share movements.\nPre-IPO share incentives stood at 2.22 million outstanding options, while post-IPO share options were 18.02 million. No additional shares were issued or canceled under these plans. The post-IPO plan allows for a maximum of 120.03 million shares to be issued or transferred. No funds were raised from share-option exercises in the reporting period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1120684455","isCrawlerRequest":true}